Index by author

01 March 2007; volume 29, issue 3

A

  1. Adamzik, M.

    1. Adamzik, M. et al "ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS." European Respiratory Journal 29.3 (2007): 482-488. Web. 26 Oct. 2020.

  2. Advenier, C.

    1. Naline, E. et al "Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi." European Respiratory Journal 29.3 (2007): 575-581. Web. 26 Oct. 2020.

  3. Aguirre-Jaime, A.

    1. Casanova, C. et al "The 6-min walking distance: long-term follow up in patients with COPD." European Respiratory Journal 29.3 (2007): 535-540. Web. 26 Oct. 2020.

  4. Åkesson, A.

    1. Scheja, A. et al "BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis." European Respiratory Journal 29.3 (2007): 446-452. Web. 26 Oct. 2020.

  5. Ameshima, S.

    1. Nakanishi, M. et al "Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation." European Respiratory Journal 29.3 (2007): 453-461. Web. 26 Oct. 2020.

  6. Annesi-Maesano, I.

    1. Annesi-Maesano, I. et al "Particulate matter, science and EU policy." European Respiratory Journal 29.3 (2007): 428-431. Web. 26 Oct. 2020.

  7. Aoshima, Y.

    1. Suda, T. et al "Management of interleukin-2-induced severe bronchoconstriction." European Respiratory Journal 29.3 (2007): 612-613. Web. 26 Oct. 2020.

  8. Arshad, S. H.

    1. Ramadas, R. A. et al "Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma." European Respiratory Journal 29.3 (2007): 502-508. Web. 26 Oct. 2020.

B

  1. Barát, E.

    1. Kullmann, T. et al "Exhaled breath condensate pH standardised for CO2 partial pressure." European Respiratory Journal 29.3 (2007): 496-501. Web. 26 Oct. 2020.

  2. Barlesi, F.

    1. Thomas, P. et al "Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies." European Respiratory Journal 29.3 (2007): 565-570. Web. 26 Oct. 2020.

  3. Barnes, P. J.

    1. Barnes, P. J.. "Scientific rationale for using a single inhaler for asthma control." European Respiratory Journal 29.3 (2007): 587-595. Web. 26 Oct. 2020.

  4. Barta, I.

    1. Kullmann, T. et al "Exhaled breath condensate pH standardised for CO2 partial pressure." European Respiratory Journal 29.3 (2007): 496-501. Web. 26 Oct. 2020.

  5. Beiderlinden, M.

    1. Adamzik, M. et al "ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS." European Respiratory Journal 29.3 (2007): 482-488. Web. 26 Oct. 2020.

  6. Bergeron, C.

    1. Bergeron, C., M. K. Tulic, and Q. Hamid. "Tools used to measure airway remodelling in research." European Respiratory Journal 29.3 (2007): 596-604. Web. 26 Oct. 2020.

  7. Blasi, F.

    1. Migliori, G. B. et al "125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic?." European Respiratory Journal 29.3 (2007): 423-427. Web. 26 Oct. 2020.

  8. Boomsma, D. I.

    1. van Beijsterveldt, C. E. M., and D. I. Boomsma. "Genetics of parentally reported asthma, eczema and rhinitis in 5-yr-old twins." European Respiratory Journal 29.3 (2007): 516-521. Web. 26 Oct. 2020.

  9. Bossink, A. W. J.

    1. van Leeuwen, R. M. L., A. W. J. Bossink, and S. F. T. Thijsen. "Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay." European Respiratory Journal 29.3 (2007): 605-607. Web. 26 Oct. 2020.

  10. Bradley, J. M.

    1. Lavery, K. et al "Self-management in bronchiectasis: the patients' perspective." European Respiratory Journal 29.3 (2007): 541-547. Web. 26 Oct. 2020.

  11. Brunekref, B.

    1. Annesi-Maesano, I. et al "Particulate matter, science and EU policy." European Respiratory Journal 29.3 (2007): 428-431. Web. 26 Oct. 2020.

C

  1. Carvalho, C. R. R.

    1. Jardim, C. et al "Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study." European Respiratory Journal 29.3 (2007): 476-481. Web. 26 Oct. 2020.

  2. Casanova, C.

    1. Casanova, C. et al "The 6-min walking distance: long-term follow up in patients with COPD." European Respiratory Journal 29.3 (2007): 535-540. Web. 26 Oct. 2020.

  3. Celli, B. R.

    1. Casanova, C. et al "The 6-min walking distance: long-term follow up in patients with COPD." European Respiratory Journal 29.3 (2007): 535-540. Web. 26 Oct. 2020.

  4. Champion, H. C.

    1. Mathai, S. C. et al "Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension." European Respiratory Journal 29.3 (2007): 469-475. Web. 26 Oct. 2020.

  5. Chiba, Y.

    1. Nakanishi, M. et al "Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation." European Respiratory Journal 29.3 (2007): 453-461. Web. 26 Oct. 2020.

  6. Chida, K.

    1. Suda, T. et al "Management of interleukin-2-induced severe bronchoconstriction." European Respiratory Journal 29.3 (2007): 612-613. Web. 26 Oct. 2020.

  7. Cote, C. G.

    1. Casanova, C. et al "The 6-min walking distance: long-term follow up in patients with COPD." European Respiratory Journal 29.3 (2007): 535-540. Web. 26 Oct. 2020.

  8. Cunha, F. Q.

    1. Scheicher, M. E. et al "Eotaxin-2 in sputum cell culture to evaluate asthma inflammation." European Respiratory Journal 29.3 (2007): 489-495. Web. 26 Oct. 2020.

D

  1. de Boer, W. I.

    1. Hylkema, M. N. et al "Tobacco use in relation to COPD and asthma." European Respiratory Journal 29.3 (2007): 438-445. Web. 26 Oct. 2020.

  2. Demura, Y.

    1. Nakanishi, M. et al "Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation." European Respiratory Journal 29.3 (2007): 453-461. Web. 26 Oct. 2020.

  3. de Torres, J. P.

    1. Casanova, C. et al "The 6-min walking distance: long-term follow up in patients with COPD." European Respiratory Journal 29.3 (2007): 535-540. Web. 26 Oct. 2020.

  4. Doddoli, C.

    1. Thomas, P. et al "Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies." European Respiratory Journal 29.3 (2007): 565-570. Web. 26 Oct. 2020.

  5. Dodge, J. A.

    1. Dodge, J. A. et al "Cystic fibrosis mortality and survival in the UK: 1947–2003." European Respiratory Journal 29.3 (2007): 522-526. Web. 26 Oct. 2020.

  6. Donaldson, G. C.

    1. Perera, W. R. et al "Inflammatory changes, recovery and recurrence at COPD exacerbation." European Respiratory Journal 29.3 (2007): 527-534. Web. 26 Oct. 2020.

  7. Dordelly, L.

    1. Casanova, C. et al "The 6-min walking distance: long-term follow up in patients with COPD." European Respiratory Journal 29.3 (2007): 535-540. Web. 26 Oct. 2020.

  8. Dorfmüller, P.

    1. Perros, F. et al "Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension." European Respiratory Journal 29.3 (2007): 462-468. Web. 26 Oct. 2020.

  9. Durand-Gasselin, I.

    1. Perros, F. et al "Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension." European Respiratory Journal 29.3 (2007): 462-468. Web. 26 Oct. 2020.

E

  1. Edwards, J.

    1. Munavvar, M. et al "The autoclavable semirigid thoracoscope: the way forward in pleural disease?." European Respiratory Journal 29.3 (2007): 571-574. Web. 26 Oct. 2020.

  2. Elborn, J. S.

    1. Lavery, K. et al "Self-management in bronchiectasis: the patients' perspective." European Respiratory Journal 29.3 (2007): 541-547. Web. 26 Oct. 2020.

  3. Ellis, S.

    1. Scheja, A. et al "BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis." European Respiratory Journal 29.3 (2007): 446-452. Web. 26 Oct. 2020.

  4. Emilie, D.

    1. Perros, F. et al "Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension." European Respiratory Journal 29.3 (2007): 462-468. Web. 26 Oct. 2020.

  5. Enomoto, N.

    1. Suda, T. et al "Management of interleukin-2-induced severe bronchoconstriction." European Respiratory Journal 29.3 (2007): 612-613. Web. 26 Oct. 2020.

  6. Ewart, S. L.

    1. Ramadas, R. A. et al "Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma." European Respiratory Journal 29.3 (2007): 502-508. Web. 26 Oct. 2020.

F

  1. Fairhurst, R. A.

    1. Naline, E. et al "Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi." European Respiratory Journal 29.3 (2007): 575-581. Web. 26 Oct. 2020.

  2. Falagas, M. E.

    1. Siempos, I. I. et al "Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia." European Respiratory Journal 29.3 (2007): 548-560. Web. 26 Oct. 2020.

  3. Fernandez, P.

    1. Stockley, R. A. et al "Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development." European Respiratory Journal 29.3 (2007): 582-586. Web. 26 Oct. 2020.

  4. Filho, J. T.

    1. Scheicher, M. E. et al "Eotaxin-2 in sputum cell culture to evaluate asthma inflammation." European Respiratory Journal 29.3 (2007): 489-495. Web. 26 Oct. 2020.

  5. Fisher, M. R.

    1. Mathai, S. C. et al "Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension." European Respiratory Journal 29.3 (2007): 469-475. Web. 26 Oct. 2020.

  6. Forastiere, F.

    1. Annesi-Maesano, I. et al "Particulate matter, science and EU policy." European Respiratory Journal 29.3 (2007): 428-431. Web. 26 Oct. 2020.

  7. Frey, U.

    1. Adamzik, M. et al "ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS." European Respiratory Journal 29.3 (2007): 482-488. Web. 26 Oct. 2020.

  8. Fuentes, P.

    1. Thomas, P. et al "Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies." European Respiratory Journal 29.3 (2007): 565-570. Web. 26 Oct. 2020.

  9. Fujisawa, T.

    1. Suda, T. et al "Management of interleukin-2-induced severe bronchoconstriction." European Respiratory Journal 29.3 (2007): 612-613. Web. 26 Oct. 2020.

G

  1. Girgis, R. E.

    1. Mathai, S. C. et al "Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension." European Respiratory Journal 29.3 (2007): 469-475. Web. 26 Oct. 2020.

  2. Giudicelli, R.

    1. Thomas, P. et al "Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies." European Respiratory Journal 29.3 (2007): 565-570. Web. 26 Oct. 2020.

H

  1. Hamid, Q.

    1. Bergeron, C., M. K. Tulic, and Q. Hamid. "Tools used to measure airway remodelling in research." European Respiratory Journal 29.3 (2007): 596-604. Web. 26 Oct. 2020.

  2. Hansson, L.

    1. Scheja, A. et al "BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis." European Respiratory Journal 29.3 (2007): 446-452. Web. 26 Oct. 2020.

  3. Hashizume, H.

    1. Suda, T. et al "Management of interleukin-2-induced severe bronchoconstriction." European Respiratory Journal 29.3 (2007): 612-613. Web. 26 Oct. 2020.

  4. Hassoun, P. M.

    1. Mathai, S. C. et al "Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension." European Respiratory Journal 29.3 (2007): 469-475. Web. 26 Oct. 2020.

  5. Haverinen-Shaughnessy, U.

    1. Pekkanen, J. et al "Moisture damage and childhood asthma: a population-based incident case–control study." European Respiratory Journal 29.3 (2007): 509-515. Web. 26 Oct. 2020.

  6. Hervé, P.

    1. Perros, F. et al "Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension." European Respiratory Journal 29.3 (2007): 462-468. Web. 26 Oct. 2020.

  7. Hoeper, M. M.

    1. Hoeper, M. M.. "Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value." European Respiratory Journal 29.3 (2007): 432-434. Web. 26 Oct. 2020.

  8. Horváth, I.

    1. Kullmann, T. et al "Exhaled breath condensate pH standardised for CO2 partial pressure." European Respiratory Journal 29.3 (2007): 496-501. Web. 26 Oct. 2020.

  9. Hoskyns, W.

    1. Panickar, J. R., and W. Hoskyns. "Treatment failure in tuberculosis." European Respiratory Journal 29.3 (2007): 561-564. Web. 26 Oct. 2020.

  10. Housten-Harris, T.

    1. Mathai, S. C. et al "Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension." European Respiratory Journal 29.3 (2007): 469-475. Web. 26 Oct. 2020.

  11. Huebner, M.

    1. Ramadas, R. A. et al "Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma." European Respiratory Journal 29.3 (2007): 502-508. Web. 26 Oct. 2020.

  12. Humbert, M.

    1. Perros, F. et al "Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension." European Respiratory Journal 29.3 (2007): 462-468. Web. 26 Oct. 2020.
    2. Jardim, C. et al "Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study." European Respiratory Journal 29.3 (2007): 476-481. Web. 26 Oct. 2020.

  13. Hurst, J. R.

    1. Perera, W. R. et al "Inflammatory changes, recovery and recurrence at COPD exacerbation." European Respiratory Journal 29.3 (2007): 527-534. Web. 26 Oct. 2020.

  14. Hylkema, M. N.

    1. Hylkema, M. N. et al "Tobacco use in relation to COPD and asthma." European Respiratory Journal 29.3 (2007): 438-445. Web. 26 Oct. 2020.

  15. Hyvärinen, A.

    1. Pekkanen, J. et al "Moisture damage and childhood asthma: a population-based incident case–control study." European Respiratory Journal 29.3 (2007): 509-515. Web. 26 Oct. 2020.

I

  1. Inui, N.

    1. Suda, T. et al "Management of interleukin-2-induced severe bronchoconstriction." European Respiratory Journal 29.3 (2007): 612-613. Web. 26 Oct. 2020.

  2. Ishizaki, T.

    1. Nakanishi, M. et al "Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation." European Respiratory Journal 29.3 (2007): 453-461. Web. 26 Oct. 2020.

  3. Itoh, H.

    1. Nakanishi, M. et al "Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation." European Respiratory Journal 29.3 (2007): 453-461. Web. 26 Oct. 2020.

J

  1. Jardim, C.

    1. Jardim, C. et al "Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study." European Respiratory Journal 29.3 (2007): 476-481. Web. 26 Oct. 2020.

  2. Jasinowodolinski, D.

    1. Jardim, C. et al "Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study." European Respiratory Journal 29.3 (2007): 476-481. Web. 26 Oct. 2020.

K

  1. Kalomenidis, I.

    1. Moschos, C. et al "A 35-year-old male with chronic cough." European Respiratory Journal 29.3 (2007): 608-611. Web. 26 Oct. 2020.

  2. Karmaus, W.

    1. Ramadas, R. A. et al "Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma." European Respiratory Journal 29.3 (2007): 502-508. Web. 26 Oct. 2020.

  3. Khan, M. A. I.

    1. Munavvar, M. et al "The autoclavable semirigid thoracoscope: the way forward in pleural disease?." European Respiratory Journal 29.3 (2007): 571-574. Web. 26 Oct. 2020.

  4. Kim, D-Y.

    1. Ramadas, R. A. et al "Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma." European Respiratory Journal 29.3 (2007): 502-508. Web. 26 Oct. 2020.

  5. Kitaichi, M.

    1. Nakanishi, M. et al "Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation." European Respiratory Journal 29.3 (2007): 453-461. Web. 26 Oct. 2020.

  6. Knemeyer, L.

    1. Adamzik, M. et al "ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS." European Respiratory Journal 29.3 (2007): 482-488. Web. 26 Oct. 2020.

  7. Kollai, M.

    1. Kullmann, T. et al "Exhaled breath condensate pH standardised for CO2 partial pressure." European Respiratory Journal 29.3 (2007): 496-501. Web. 26 Oct. 2020.

  8. Korppi, M.

    1. Pekkanen, J. et al "Moisture damage and childhood asthma: a population-based incident case–control study." European Respiratory Journal 29.3 (2007): 509-515. Web. 26 Oct. 2020.

  9. Kullmann, T.

    1. Kullmann, T. et al "Exhaled breath condensate pH standardised for CO2 partial pressure." European Respiratory Journal 29.3 (2007): 496-501. Web. 26 Oct. 2020.

  10. Kunzli, N.

    1. Annesi-Maesano, I. et al "Particulate matter, science and EU policy." European Respiratory Journal 29.3 (2007): 428-431. Web. 26 Oct. 2020.

L

  1. Lambrecht, B. N.

    1. Lambrecht, B. N., and L. M. van den Toorn. "The pressure mounts on lung dendritic cells." European Respiratory Journal 29.3 (2007): 435-437. Web. 26 Oct. 2020.

  2. Larsen, K.

    1. Scheja, A. et al "BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis." European Respiratory Journal 29.3 (2007): 446-452. Web. 26 Oct. 2020.

  3. Lavery, K.

    1. Lavery, K. et al "Self-management in bronchiectasis: the patients' perspective." European Respiratory Journal 29.3 (2007): 541-547. Web. 26 Oct. 2020.

  4. Lázár, Z.

    1. Kullmann, T. et al "Exhaled breath condensate pH standardised for CO2 partial pressure." European Respiratory Journal 29.3 (2007): 496-501. Web. 26 Oct. 2020.

  5. Lewis, P. A.

    1. Dodge, J. A. et al "Cystic fibrosis mortality and survival in the UK: 1947–2003." European Respiratory Journal 29.3 (2007): 522-526. Web. 26 Oct. 2020.

  6. Loddenkemper, R.

    1. Migliori, G. B. et al "125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic?." European Respiratory Journal 29.3 (2007): 423-427. Web. 26 Oct. 2020.

  7. Luisetti, M.

    1. Stockley, R. A. et al "Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development." European Respiratory Journal 29.3 (2007): 582-586. Web. 26 Oct. 2020.

M

  1. Manta, K. G.

    1. Siempos, I. I. et al "Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia." European Respiratory Journal 29.3 (2007): 548-560. Web. 26 Oct. 2020.

  2. Marin, J. M.

    1. Casanova, C. et al "The 6-min walking distance: long-term follow up in patients with COPD." European Respiratory Journal 29.3 (2007): 535-540. Web. 26 Oct. 2020.

  3. Mathai, S. C.

    1. Mathai, S. C. et al "Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension." European Respiratory Journal 29.3 (2007): 469-475. Web. 26 Oct. 2020.

  4. Matthews, S.

    1. Ramadas, R. A. et al "Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma." European Respiratory Journal 29.3 (2007): 502-508. Web. 26 Oct. 2020.

  5. Mazmanian, M.

    1. Perros, F. et al "Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension." European Respiratory Journal 29.3 (2007): 462-468. Web. 26 Oct. 2020.

  6. Mendez, R.

    1. Casanova, C. et al "The 6-min walking distance: long-term follow up in patients with COPD." European Respiratory Journal 29.3 (2007): 535-540. Web. 26 Oct. 2020.

  7. Michelet, P.

    1. Thomas, P. et al "Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies." European Respiratory Journal 29.3 (2007): 565-570. Web. 26 Oct. 2020.

  8. Migliori, G. B.

    1. Migliori, G. B. et al "125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic?." European Respiratory Journal 29.3 (2007): 423-427. Web. 26 Oct. 2020.

  9. Mills, J.

    1. Munavvar, M. et al "The autoclavable semirigid thoracoscope: the way forward in pleural disease?." European Respiratory Journal 29.3 (2007): 571-574. Web. 26 Oct. 2020.

  10. Miravitlles, M.

    1. Stockley, R. A. et al "Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development." European Respiratory Journal 29.3 (2007): 582-586. Web. 26 Oct. 2020.

  11. Miyamori, I.

    1. Nakanishi, M. et al "Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation." European Respiratory Journal 29.3 (2007): 453-461. Web. 26 Oct. 2020.

  12. Mizuno, S.

    1. Nakanishi, M. et al "Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation." European Respiratory Journal 29.3 (2007): 453-461. Web. 26 Oct. 2020.

  13. Molimard, M.

    1. Naline, E. et al "Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi." European Respiratory Journal 29.3 (2007): 575-581. Web. 26 Oct. 2020.

  14. Moschos, C.

    1. Moschos, C. et al "A 35-year-old male with chronic cough." European Respiratory Journal 29.3 (2007): 608-611. Web. 26 Oct. 2020.

  15. Müllerova, H.

    1. Perera, W. R. et al "Inflammatory changes, recovery and recurrence at COPD exacerbation." European Respiratory Journal 29.3 (2007): 527-534. Web. 26 Oct. 2020.

  16. Munavvar, M.

    1. Munavvar, M. et al "The autoclavable semirigid thoracoscope: the way forward in pleural disease?." European Respiratory Journal 29.3 (2007): 571-574. Web. 26 Oct. 2020.

  17. Mussot, S.

    1. Perros, F. et al "Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension." European Respiratory Journal 29.3 (2007): 462-468. Web. 26 Oct. 2020.

N

  1. Nakamura, Y.

    1. Suda, T. et al "Management of interleukin-2-induced severe bronchoconstriction." European Respiratory Journal 29.3 (2007): 612-613. Web. 26 Oct. 2020.

  2. Nakanishi, M.

    1. Nakanishi, M. et al "Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation." European Respiratory Journal 29.3 (2007): 453-461. Web. 26 Oct. 2020.

  3. Naline, E.

    1. Naline, E. et al "Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi." European Respiratory Journal 29.3 (2007): 575-581. Web. 26 Oct. 2020.

  4. Nevalainen, A.

    1. Pekkanen, J. et al "Moisture damage and childhood asthma: a population-based incident case–control study." European Respiratory Journal 29.3 (2007): 509-515. Web. 26 Oct. 2020.

O

  1. O'Neill, B.

    1. Lavery, K. et al "Self-management in bronchiectasis: the patients' perspective." European Respiratory Journal 29.3 (2007): 541-547. Web. 26 Oct. 2020.

P

  1. Panickar, J. R.

    1. Panickar, J. R., and W. Hoskyns. "Treatment failure in tuberculosis." European Respiratory Journal 29.3 (2007): 561-564. Web. 26 Oct. 2020.

  2. Pekkanen, J.

    1. Pekkanen, J. et al "Moisture damage and childhood asthma: a population-based incident case–control study." European Respiratory Journal 29.3 (2007): 509-515. Web. 26 Oct. 2020.

  3. Perera, W. R.

    1. Perera, W. R. et al "Inflammatory changes, recovery and recurrence at COPD exacerbation." European Respiratory Journal 29.3 (2007): 527-534. Web. 26 Oct. 2020.

  4. Perros, F.

    1. Perros, F. et al "Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension." European Respiratory Journal 29.3 (2007): 462-468. Web. 26 Oct. 2020.

  5. Peters, J.

    1. Adamzik, M. et al "ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS." European Respiratory Journal 29.3 (2007): 482-488. Web. 26 Oct. 2020.

  6. Piitulainen, E.

    1. Stockley, R. A. et al "Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development." European Respiratory Journal 29.3 (2007): 582-586. Web. 26 Oct. 2020.

  7. Postma, D. S.

    1. Hylkema, M. N. et al "Tobacco use in relation to COPD and asthma." European Respiratory Journal 29.3 (2007): 438-445. Web. 26 Oct. 2020.

  8. Putus, T.

    1. Pekkanen, J. et al "Moisture damage and childhood asthma: a population-based incident case–control study." European Respiratory Journal 29.3 (2007): 509-515. Web. 26 Oct. 2020.

R

  1. Ramadas, R. A.

    1. Ramadas, R. A. et al "Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma." European Respiratory Journal 29.3 (2007): 502-508. Web. 26 Oct. 2020.

  2. Raviglione, M. C.

    1. Migliori, G. B. et al "125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic?." European Respiratory Journal 29.3 (2007): 423-427. Web. 26 Oct. 2020.

  3. Reilly, J.

    1. Lavery, K. et al "Self-management in bronchiectasis: the patients' perspective." European Respiratory Journal 29.3 (2007): 541-547. Web. 26 Oct. 2020.

  4. Rochitte, C. E.

    1. Jardim, C. et al "Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study." European Respiratory Journal 29.3 (2007): 476-481. Web. 26 Oct. 2020.

  5. Roussos, C.

    1. Moschos, C. et al "A 35-year-old male with chronic cough." European Respiratory Journal 29.3 (2007): 608-611. Web. 26 Oct. 2020.

  6. Rubenfeld, G.

    1. Jardim, C. et al "Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study." European Respiratory Journal 29.3 (2007): 476-481. Web. 26 Oct. 2020.

S

  1. Sadeghnejad, A.

    1. Ramadas, R. A. et al "Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma." European Respiratory Journal 29.3 (2007): 502-508. Web. 26 Oct. 2020.

  2. Sapsford, R. J.

    1. Perera, W. R. et al "Inflammatory changes, recovery and recurrence at COPD exacerbation." European Respiratory Journal 29.3 (2007): 527-534. Web. 26 Oct. 2020.

  3. Sato, J.

    1. Suda, T. et al "Management of interleukin-2-induced severe bronchoconstriction." European Respiratory Journal 29.3 (2007): 612-613. Web. 26 Oct. 2020.

  4. Scheicher, M. E.

    1. Scheicher, M. E. et al "Eotaxin-2 in sputum cell culture to evaluate asthma inflammation." European Respiratory Journal 29.3 (2007): 489-495. Web. 26 Oct. 2020.

  5. Scheja, A.

    1. Scheja, A. et al "BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis." European Respiratory Journal 29.3 (2007): 446-452. Web. 26 Oct. 2020.

  6. Siempos, I. I.

    1. Siempos, I. I. et al "Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia." European Respiratory Journal 29.3 (2007): 548-560. Web. 26 Oct. 2020.

  7. Siffert, W.

    1. Adamzik, M. et al "ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS." European Respiratory Journal 29.3 (2007): 482-488. Web. 26 Oct. 2020.

  8. Simonneau, G.

    1. Perros, F. et al "Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension." European Respiratory Journal 29.3 (2007): 462-468. Web. 26 Oct. 2020.

  9. Sixt, S.

    1. Adamzik, M. et al "ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS." European Respiratory Journal 29.3 (2007): 482-488. Web. 26 Oct. 2020.

  10. Souza, R.

    1. Perros, F. et al "Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension." European Respiratory Journal 29.3 (2007): 462-468. Web. 26 Oct. 2020.
    2. Jardim, C. et al "Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study." European Respiratory Journal 29.3 (2007): 476-481. Web. 26 Oct. 2020.

  11. Stanton, M.

    1. Dodge, J. A. et al "Cystic fibrosis mortality and survival in the UK: 1947–2003." European Respiratory Journal 29.3 (2007): 522-526. Web. 26 Oct. 2020.

  12. Stathopoulos, G. T.

    1. Moschos, C. et al "A 35-year-old male with chronic cough." European Respiratory Journal 29.3 (2007): 608-611. Web. 26 Oct. 2020.

  13. Sterk, P. J.

    1. Hylkema, M. N. et al "Tobacco use in relation to COPD and asthma." European Respiratory Journal 29.3 (2007): 438-445. Web. 26 Oct. 2020.

  14. Stockley, R. A.

    1. Stockley, R. A. et al "Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development." European Respiratory Journal 29.3 (2007): 582-586. Web. 26 Oct. 2020.

  15. Suda, T.

    1. Suda, T. et al "Management of interleukin-2-induced severe bronchoconstriction." European Respiratory Journal 29.3 (2007): 612-613. Web. 26 Oct. 2020.

  16. Szili, B.

    1. Kullmann, T. et al "Exhaled breath condensate pH standardised for CO2 partial pressure." European Respiratory Journal 29.3 (2007): 496-501. Web. 26 Oct. 2020.

T

  1. Teixeira, A. L.

    1. Scheicher, M. E. et al "Eotaxin-2 in sputum cell culture to evaluate asthma inflammation." European Respiratory Journal 29.3 (2007): 489-495. Web. 26 Oct. 2020.

  2. Teixeira, M. M.

    1. Scheicher, M. E. et al "Eotaxin-2 in sputum cell culture to evaluate asthma inflammation." European Respiratory Journal 29.3 (2007): 489-495. Web. 26 Oct. 2020.

  3. Thijsen, S. F. T.

    1. van Leeuwen, R. M. L., A. W. J. Bossink, and S. F. T. Thijsen. "Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay." European Respiratory Journal 29.3 (2007): 605-607. Web. 26 Oct. 2020.

  4. Thirion, X.

    1. Thomas, P. et al "Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies." European Respiratory Journal 29.3 (2007): 565-570. Web. 26 Oct. 2020.

  5. Thomas, P.

    1. Thomas, P. et al "Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies." European Respiratory Journal 29.3 (2007): 565-570. Web. 26 Oct. 2020.

  6. Todorova, L.

    1. Scheja, A. et al "BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis." European Respiratory Journal 29.3 (2007): 446-452. Web. 26 Oct. 2020.

  7. Trifilieff, A.

    1. Naline, E. et al "Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi." European Respiratory Journal 29.3 (2007): 575-581. Web. 26 Oct. 2020.

  8. Tufvesson, E.

    1. Scheja, A. et al "BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis." European Respiratory Journal 29.3 (2007): 446-452. Web. 26 Oct. 2020.

  9. Tulic, M. K.

    1. Bergeron, C., M. K. Tulic, and Q. Hamid. "Tools used to measure airway remodelling in research." European Respiratory Journal 29.3 (2007): 596-604. Web. 26 Oct. 2020.

V

  1. Valyon, M.

    1. Kullmann, T. et al "Exhaled breath condensate pH standardised for CO2 partial pressure." European Respiratory Journal 29.3 (2007): 496-501. Web. 26 Oct. 2020.

  2. van Beijsterveldt, C. E. M.

    1. van Beijsterveldt, C. E. M., and D. I. Boomsma. "Genetics of parentally reported asthma, eczema and rhinitis in 5-yr-old twins." European Respiratory Journal 29.3 (2007): 516-521. Web. 26 Oct. 2020.

  3. van den Toorn, L. M.

    1. Lambrecht, B. N., and L. M. van den Toorn. "The pressure mounts on lung dendritic cells." European Respiratory Journal 29.3 (2007): 435-437. Web. 26 Oct. 2020.

  4. van Leeuwen, R. M. L.

    1. van Leeuwen, R. M. L., A. W. J. Bossink, and S. F. T. Thijsen. "Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay." European Respiratory Journal 29.3 (2007): 605-607. Web. 26 Oct. 2020.

  5. Vardakas, K. Z.

    1. Siempos, I. I. et al "Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia." European Respiratory Journal 29.3 (2007): 548-560. Web. 26 Oct. 2020.

  6. Vianna, E. O.

    1. Scheicher, M. E. et al "Eotaxin-2 in sputum cell culture to evaluate asthma inflammation." European Respiratory Journal 29.3 (2007): 489-495. Web. 26 Oct. 2020.

W

  1. Waqaruddin, Z.

    1. Munavvar, M. et al "The autoclavable semirigid thoracoscope: the way forward in pleural disease?." European Respiratory Journal 29.3 (2007): 571-574. Web. 26 Oct. 2020.

  2. Wedzicha, J. A.

    1. Perera, W. R. et al "Inflammatory changes, recovery and recurrence at COPD exacerbation." European Respiratory Journal 29.3 (2007): 527-534. Web. 26 Oct. 2020.

  3. Westergren Thorsson, G.

    1. Scheja, A. et al "BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis." European Respiratory Journal 29.3 (2007): 446-452. Web. 26 Oct. 2020.

  4. Wildt, M.

    1. Scheja, A. et al "BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis." European Respiratory Journal 29.3 (2007): 446-452. Web. 26 Oct. 2020.

  5. Wilkinson, T. M. A.

    1. Perera, W. R. et al "Inflammatory changes, recovery and recurrence at COPD exacerbation." European Respiratory Journal 29.3 (2007): 527-534. Web. 26 Oct. 2020.

  6. Wilsher, J.

    1. Dodge, J. A. et al "Cystic fibrosis mortality and survival in the UK: 1947–2003." European Respiratory Journal 29.3 (2007): 522-526. Web. 26 Oct. 2020.

Y

  1. Yokomura, K.

    1. Suda, T. et al "Management of interleukin-2-induced severe bronchoconstriction." European Respiratory Journal 29.3 (2007): 612-613. Web. 26 Oct. 2020.

Z

  1. Zaiman, A.

    1. Mathai, S. C. et al "Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension." European Respiratory Journal 29.3 (2007): 469-475. Web. 26 Oct. 2020.
Back to top
European Respiratory Journal: 29 (3)

Search Within This Issue

Jump to

Manage Table of content Alerts